The market is waiting for quarterly results from BLMH.c Bloom Health Partners (CSE: BLMH) shares continue to trade with very low volume. This shows me that past buyers are holding, and potential buyers are waiting for a big announcement to establish a position.
The news everyone is waiting for is fiscal quarterly results. BLMH showed very impressive growth in FQ2, reporting $11.1 million in revenue. This brought the company’s yearly earnings to $16.9 million. For a company currently valued at $9.22 million, this shows a massive undervaluation.
If the company is able to report FQ3 earnings that show continued growth from FQ2, this stock is going to skyrocket. Even if the company’s valuation grows to only 2x current earnings, share price will be in the $.357 range. This is, however, an extremely conservative estimate if the company reports equally strong FQ3 results.
BLMH.c is currently trading at $.195.
https://ceo.ca/@newsfile/bloom-health-partners-reports-profitable-fiscal-q2